Literature DB >> 125255

An in vitro inhibitor of Na-K-ATPase present in an adenosinetriphosphate preparation.

A N Charney, P Silva, F H Epstein.   

Abstract

An in vitro inhibitor of Na-K-ATPase was discovered in a commonly used preparation of ATP made by the Sigma Chemical Company, St. Louis, Mo. (Sigma grade ATP). As measured by a reliable and widely used assay system in which phosphate liberation in measured colorimetrically, Na-K-ATPase activity in the rat kidney, small intestine and colon was about 50% lower then Sigma grade ATP was used as substrate as compared to another Sigma Chemical Company product II ATP. Mg-ATPase and adenylate cyclase assays were unaffected by substituting Sigma grade for grade II ATP. The inhibitor of Na-K-ATPase could not be identified. Sigma grade ATP probably should not be used when measuring the activity of Na-K-ATPase in the rat kidney, small intestine, or colon.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 125255     DOI: 10.1152/jappl.1975.39.1.156

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  4 in total

1.  Theophylline-induced fluid and electrolyte sectetion by rabbit ileum results from negative anomalous osmotic flow across the tight-junction [proceedings].

Authors:  G D Holman; R J Naftalin
Journal:  J Physiol       Date:  1976-12       Impact factor: 5.182

2.  Negative inotropic effect of vanadate in ventricular myocardium in the presence of 3-isobutyl-1-methylxanthine or isoprenaline.

Authors:  R Brückner; W Schmitz; H Scholz; A Schumacher; E Erdmann; W Krawietz; K Werdan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

3.  The effect of vanadate on human kidney potassium dependent phosphatase.

Authors:  G L Nieder; C N Corder; P A Culp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

4.  The effects of vanadate on the fluxes of sodium and potassium ions through the sodium pump.

Authors:  L A Beaugé; J J Cavieres; J J Grantham
Journal:  J Physiol       Date:  1980-04       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.